Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 4317

Movement disorder biotech Vima steps onto scene with $60M

$
0
0
Since Bernard Ravina's medical training in neurology in the 1990s, there have been few new therapies that treat a movement disorder known as dystonia. "Nothing fundamentally has changed for these patients since then," the drug ...

Viewing all articles
Browse latest Browse all 4317

Latest Images

Trending Articles



Latest Images